CII
ABT icon

CR Intrinsic Investors’s Abbott ABT Stock Holding History

CR Intrinsic Investors’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-50,000
Closed -$1.66M – 267
2013
Q3 		$1.66M Sell
50,000
-225,000
-82% -$7.89M 0.05% 302
2013
Q2 		$9.59M Buy
+275,000
New +$10.1M 0.33% 114

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

CR Intrinsic Investors's ABT Position: Q4 2013 in Review

CR Intrinsic Investors sold out of Abbott (ABT) in Q4 2013, closing a stake of 50,000 shares — an estimated $1.66M sold.

CR Intrinsic Investors first reported a position in ABT in Q2 2013 and held it in 2 quarters. The position peaked at $9.59M in Q2 2013. 1,383 funds tracked by Wall St. Rank hold ABT as of Q4 2013.

  • CR Intrinsic Investors reported no remaining Abbott position as of Q4 2013 after selling out during the quarter.
  • CR Intrinsic Investors sold 50,000 Abbott shares in Q4 2013, an estimated $1.66M.
  • CR Intrinsic Investors first reported a position in Abbott in Q2 2013 and held it in 2 quarters.
  • CR Intrinsic Investors's Abbott position peaked at $9.59M in Q2 2013.
  • 1,383 funds tracked by Wall St. Rank held Abbott as of Q4 2013.

Based on CR Intrinsic Investors's 13F filing for Q4 2013, filed 14 Feb 2014.